Ennov to Exhibit at the 2022 World Drug Safety Congress Europe

August 22, 2022

Ennov will exhibit at the 2022 World Drug Safety Congress Europe being held on 27-29 September 2022 in Amsterdam, RAI Congress Centre.

As Europe’s principal Drug Safety & PV Event, the World Drug Safety Congress Europe provides patients, physicians, pharma, biotech and consumers with the tools to make the best drug safety decisions. More than 600+ key thought leaders explore pharmacovigilance challenges. 

Ennov is a leading Life Sciences technology vendor with solutions that span the drug development continuum including Regulatory, Clinical, Pharmacovigilance, Quality, and Event Management

Ennov’s Pharmacovigilance suite keeps the collection, management, assessment, and reporting of human or veterinary adverse events in one unified database while also providing advanced signal detection and PV data analysis tools. Our software is currently being used by pharmaceutical, biological and device enterprises, contract manufacturers, CROs and leading health authorities around the world.

Stop by booth #39 and visit Ennov while at the 2022 World Drug Safety Congress Europe to learn more about Ennov’s Pharmacovigilance solutions.

About Ennov

Ennov provides a comprehensive software platform to manage the most demanding processes of life sciences organizations in a compliant and efficient way. With over 20 years of experience, Ennov’s cloud-based solutions cover Regulatory Affairs, Pharmacovigilance, Quality, Clinical, and Document Management. Dedicated to innovation and excellence, Ennov’s solutions are used by more than 450 Life Science companies and 500,000 users worldwide, helping them to bring their products to market faster while maintaining compliance with regulatory requirements.

Share :

Facebook
Twitter
LinkedIn

Register for free to access to our library of exclusive content!

Highlight Post

Recent Posts